Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

Condition:   Rotavirus Vaccine Interventions:   Biological: RV3-BB;   Biological: Trivalent P2-VP8;   Biological: Rotarix;   Biological: RV3-BB birth dose;   Biological: Trivalent P2-VP8 Booster dose Sponsors:   PATH;   SK Bioscience Co., Ltd.;   Murdoch Childrens Research Institute;   Children's Hospital Medical Center, Cincinnati;   Bill and Melinda Gates Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials